Skip to content

Effect of a computer-based mental training programme on attention, self-control and treatment adherence in people with lupus

Effect of computerized cognitive training on executive functioning and treatment adherence compared to standard intervention in patients with systemic lupus erythematosus (SLE): a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11380316
Enrollment
180
Registered
2026-01-24
Start date
2025-12-06
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive intervention in patients with systemic lupus erythematosus Skin and Connective Tissue Diseases

Interventions

The study will be conducted in the city of Manizales, Colombia, using referrals from specialists allied to the research and leading medical centers specializing in the care of patients with autoimmune

Sponsors

Universidad de Manizales
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Be between 18 and 55 years of age. 2. Be biologically female. 3. Have a confirmed diagnosis of systemic lupus erythematosus (LUPUS), supported by medical reports. 4. Have the diagnosis made by a rheumatologist, who has ruled out other possible medical causes. 5. Be under pharmacological treatment that is monitored by healthcare professionals. 6. Have completed at least fifth grade of primary school. 7. Reside in a municipality of Manizales. 8. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of acquired brain damage prior to the diagnosis of systemic lupus erythematosus (LUPUS). 2. Current presence or unstable remission of affective symptoms (anxiety and/or depression) with remission lasting less than four months, or lack of clinical evidence confirming symptomatic stability. 3. History of neurodevelopmental disorders. 4. Coexistence of unstable metabolic diseases or metabolic conditions without adequate management. 5. Not having undergone a neuropsychological evaluation within the last six months. 6. Current use of psychoactive substances.

Countries

Colombia

Contacts

Public ContactAndrés Camilo;Daniel Delgado Reyes;Landinez-Martinez

;

acdelgado@umanizales.edu.co;dlandinez@umanizales.edu.co+57 3127049674;+57 (606) 8879680

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026